The consensus price target hints at a 65.7% upside potential for Sensus Healthcare (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Sensus Healthcare offers equipment for skin problems, with strong demand but vulnerable to economic instability. The company is recovering in 2024, with initiatives for recurring revenue to improve in
Here is how Sensus Healthcare, Inc. (SRTS) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
From a technical perspective, Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick, as it just reached a key level of support. SRTS recently overtook the 20-day moving average, and this
Sensus Healthcare (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Best Momentum Stocks to Buy for August 13th

11:02am, Tuesday, 13'th Aug 2024
BLBD and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 13, 2024.
The consensus price target hints at a 64.7% upside potential for Sensus Healthcare (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings

New Strong Buy Stocks for August 13th

08:21am, Tuesday, 13'th Aug 2024
BLBD, SRTS, LAKE, MPW and NYT have been added to the Zacks Rank #1 (Strong Buy) List on August 13, 2024.
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA, IR Joseph Sardano - Chairman and CEO Michael Sardano - Presid
Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to loss of $0.02 per share a year ago.
Revenues of $9.2 million compares with $4.5 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $2.1 million compares with negative $1.0 million a year ago “Fair Deal Agreemen
Investors who want to buy stocks in August might consider searching for stocks gaining more attention from Wall Street. Today we dive into Sensus Healthcare (SRTS) stock and more.
The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $6.25, representing a -1.88% change from its previous close.
BOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological an
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE